Gannex Announces Positive Clinical Results in Overweight and Obese Subjects for Its THR-β Agonist ASC41
- Sunday, February 21, 2021, 7:15
- PR Newswire
- Add a comment
SHANGHAI, Feb. 21, 2021 /PRNewswire/ — Gannex, a wholly owned company of Ascletis Pharma Inc. (HKEX: 1672), fully dedicated to the R&D and commercialization of new drugs in the field of nonalcoholic steatohepatitis (NASH), announces the positive clinical results in overweight and obese…
About the Author
admin has written 20652 stories on this site.